IRIS - Res&Arch Institutional Research Information System - Research & Archive

GRESELE, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.649
EU - Europa 9.558
AS - Asia 9.530
SA - Sud America 1.634
AF - Africa 229
Continente sconosciuto - Info sul continente non disponibili 18
OC - Oceania 10
Totale 33.628
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.386
SG - Singapore 4.269
IE - Irlanda 1.691
UA - Ucraina 1.652
HK - Hong Kong 1.635
RU - Federazione Russa 1.430
IT - Italia 1.306
BR - Brasile 1.214
CN - Cina 1.150
VN - Vietnam 1.006
SE - Svezia 803
DE - Germania 707
FR - Francia 616
FI - Finlandia 510
GB - Regno Unito 306
KR - Corea 287
TR - Turchia 271
IN - India 177
AR - Argentina 145
CA - Canada 125
BD - Bangladesh 118
IQ - Iraq 93
PL - Polonia 81
NL - Olanda 71
MX - Messico 70
JP - Giappone 69
ZA - Sudafrica 67
CO - Colombia 61
UZ - Uzbekistan 60
AT - Austria 58
CH - Svizzera 58
ES - Italia 58
PK - Pakistan 57
VE - Venezuela 55
EC - Ecuador 49
ID - Indonesia 49
SA - Arabia Saudita 47
BE - Belgio 45
PH - Filippine 35
LB - Libano 34
MA - Marocco 33
CL - Cile 32
MY - Malesia 26
PY - Paraguay 26
CZ - Repubblica Ceca 23
LT - Lituania 23
EG - Egitto 21
TN - Tunisia 21
BO - Bolivia 20
GR - Grecia 20
JO - Giordania 20
KE - Kenya 20
RO - Romania 15
AE - Emirati Arabi Uniti 14
KZ - Kazakistan 14
UY - Uruguay 14
DZ - Algeria 13
EU - Europa 13
MK - Macedonia 13
AL - Albania 12
PE - Perù 12
AZ - Azerbaigian 10
IL - Israele 10
IR - Iran 10
NI - Nicaragua 10
NP - Nepal 10
OM - Oman 10
RS - Serbia 10
JM - Giamaica 9
PS - Palestinian Territory 9
BG - Bulgaria 8
TH - Thailandia 8
CR - Costa Rica 7
ET - Etiopia 7
HN - Honduras 7
HU - Ungheria 7
PA - Panama 7
PT - Portogallo 7
TT - Trinidad e Tobago 7
AU - Australia 5
BH - Bahrain 5
DO - Repubblica Dominicana 5
LY - Libia 5
AO - Angola 4
CI - Costa d'Avorio 4
GA - Gabon 4
KW - Kuwait 4
SN - Senegal 4
SY - Repubblica araba siriana 4
TZ - Tanzania 4
XK - ???statistics.table.value.countryCode.XK??? 4
AM - Armenia 3
BB - Barbados 3
CU - Cuba 3
GT - Guatemala 3
HR - Croazia 3
LK - Sri Lanka 3
ME - Montenegro 3
NO - Norvegia 3
PR - Porto Rico 3
Totale 33.558
Salva come PNG Salva come JPEG
Città #
Singapore 2.887
Chandler 1.785
Dublin 1.678
Hong Kong 1.631
San Jose 1.018
San Mateo 906
Jacksonville 902
Ashburn 741
Boardman 533
Santa Clara 499
Moscow 484
Dong Ket 467
Altamura 434
Medford 416
Princeton 415
Lauterbourg 390
Perugia 349
Lawrence 312
Wilmington 291
Seoul 267
Ann Arbor 265
Beijing 257
Des Moines 229
Andover 211
Izmir 193
Munich 192
Ho Chi Minh City 188
Los Angeles 171
The Dalles 170
New York 142
Saint Petersburg 139
Hanoi 118
São Paulo 103
Piscataway 102
Helsinki 96
Turku 80
Norwalk 76
Tokyo 66
Frankfurt am Main 64
Orem 62
Redmond 55
Dearborn 54
Shanghai 54
Woodbridge 52
Rome 51
London 50
Denver 47
San Paolo di Civitate 46
Houston 45
Brussels 44
Dallas 44
Brooklyn 42
Rio de Janeiro 41
Johannesburg 40
Baghdad 39
Montreal 39
Warsaw 39
Nuremberg 38
Atlanta 37
Chicago 37
Stockholm 34
Chennai 32
Da Nang 31
San Diego 31
Tashkent 31
Amsterdam 29
Belo Horizonte 29
Phoenix 27
Poplar 27
Toronto 27
Falkenstein 25
Brasília 24
Ankara 23
Columbus 23
Council Bluffs 23
Curitiba 22
Manchester 22
Mexico City 22
Milan 22
Porto Alegre 22
San Francisco 20
Boston 19
Den Haag 19
Campinas 18
Dhaka 18
Guayaquil 18
Haiphong 18
Amman 17
Hải Dương 17
Jeddah 17
Nairobi 17
Ottawa 17
Quito 17
Riyadh 17
Caracas 16
Falls Church 16
Guangzhou 16
Istanbul 16
Kuala Lumpur 16
Medellín 16
Totale 21.094
Salva come PNG Salva come JPEG
Nome #
Fisiopatologia dell'emostasi 526
PIASTRINE TRASFETTATE CON MATERIALE GENETICO ESOGENO E MICROPARTICELLE DERIVATE DA DETTE PIASTRINE TRASFETTATE, METODO PER LA LORO PREPARAZIONE E LORO USI. 255
Activation of phospholipase A2 and B-thromboglobulin release in human platelets: comparative effects of thrombin and fluoroaluminate stimulation. 176
Activation of human platelet phospholipase A2 induced by phisiological agonist or fluoroaluminate: effec of inhibitors of protein kinases 175
Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. 146
5-ASA-glutamate protects rats from inflammaory bowel disease induced by intracolonic administration of trinitrobenzensulfonic acid. 145
Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study. 145
Impact of Chronic Antiplatelet Therapy prior to Hospitalization on Ischemic and Bleeding Events in Invasively Managed Patients with Acute Coronary Syndromes: The ACUITY Trial 143
Diagnosis of suspected inherited platelet function disorders: results of a worldwide survey. 139
Role of endothelial dysfunction in the thrombotic complications of COVID-19 patients 139
Albumin prevents TxB2 formation from thrombin-stimulated human platelets by sequestring the liberated arachidonic acid in the extracellular space 137
A novel congenital dysprothrombinemia leading to defective prothrombin maturation. 136
Beta 1-tubulin in human platelets: not simply a structural cell frame. 136
Misurazione del PAF (fattore attivante le piastrine) nella saliva umana; standardizzazione del metodo 135
Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo. 133
[Italian intersocietary consensus document on aspirin therapy in primary cardiovascular prevention]. 130
Abstract 15389: High On-Treatment Platelet Reactivity in Clopidogrel-Treated Patients Undergoing Elective Carotid Stenting: Correlation with Previous Cerebrovascular Events 130
Effect of aspirin treatment on abacavir-associated platelet hyperreactivity in HIV-infected patients 130
Interaction with damaged vessel wall in vivo in humans induces platelets to express CD40L resulting in endothelial activation. No effect of aspirin intake. 128
Contribution of matrix metalloproteinase 2 to joint destruction in group B Streptococcus-induced murine arthritis. 125
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia. 124
Nitric oxide and its antithrombotic action on the cardiovascular system 124
Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management 123
Platelets are essential for leukocyte recruitment in allergic inflammation. 121
Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy. 120
Impact of tenofovir versus abacavir on HIV-related endothelial dysfunction. 120
Guida alla terapia antitrombotica curata dalla Federazione Nazionale Centri per la Diagnosi della Trombosi e la Sorveglianza delle Terapie Antitrombotiche (FCSA) 120
HIV type 1 infection, and not short-term HAART, indice endothelial dysfunction. 118
Altered platelet function associated with the bronchial hyperresponsiveness accompanying nocturnal asthma 118
Effect of substituted stilbenes on platelet function 118
Activation of phospholipase A2 and ß-thromboglobulin release in human platelets stimulated with thrombin and fluoro aluminate 117
A new case of acquired Glanzmann's thrombasthenia: Diagnostic value of flow cytometry. 116
A novel mechanism regulating human platelet activation by MMP-2-mediated PAR1 biased signaling 116
Comparative evaluation of the fully automated HemosIL®AcuStar ADAMTS13 activity assay vs. ELISA: Possible interference by autoantibodies different from anti ADAMTS-13 116
C-reactive protein induces expression of matrix metalloproteinase-9: A possible link between inflammation and plaque rupture. 115
Search for SARS-CoV-2 RNA in platelets from COVID-19 patients 115
Germline GATA2 variant disrupting endothelial eNOS cell function and angiogenesis can be restored by c-Jun/AP-1 upregulation 114
A comparison of lupus anticoagulant-positive patients with clinical picture of antiphospholipid syndrome and those without. 113
Bleeding risk of surgery and its prevention in patients with inherited platelet disorders. The Surgery in Platelet disorders And Therapeutic Approach (SPATA) study 113
Dominant inheritance of a novel integrin beta3 mutation associated with a hereditary macrothrombocytopenia and platelet dysfunction in two Italian families. 112
Diagnosis of platelet-type von Willebrand disease by flow cytometry. 112
Allergen induces the migration of platelets to lung tissue in allergic asthma. 112
Defective platelet beta-N-Acetyl hexosaminidase content and release in chronic myeloproliferative disorders 111
Acquired von Willebrand syndrome type 2A in a JAK2-positive essential thrombocythaemia-affected member of a large von Willebrand disease family with a novel autosomal dominant A1716P mutation. 111
Alteration of Liver Enzymes Is a Feature of the Myh9-Related Disease Syndrome. 111
RhoA signaling through platelet P2Y1 receptor controls leukocyte recruitment in allergic mice. 110
In vivo platelet activation and platelet hyperreactivity in abacavir-treated HIV-infected patients. 110
Platelet P-selectin is required for pulmonary eosinophil and lymphocyte recruitment in a murine model of allergic inflammation 109
Cytoskeletal perturbation leads to platelet dysfunction and thrombocytopenia in variant forms of Glanzmann thrombasthenia 109
AB0952 Intra-articular low molecular weight hyaluronate reduces platelet influx and matrix metalloproteinase-2 levels in synovial fluid of patients with knee osteoarthritis 109
Cloricromene inhibits G-Protein mediated activation of phospholipase A2 in human platelets 108
Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation. 108
A novel nitric oxide-releasing statin derivative exerts and antiplatelet/antithrombotic activity and inhibits tissue factor expression. 108
Effect of cloricromene on intermittent claudication. A randomized double-blind, placebo controlled trial in patients treated with aspirin: effect on claudication distance and quality of life 107
Tardive gestosis: clinical observations. 107
Incidence of a first thromboembolic event in carriers of isolated lupus anticoagulant. 106
Nitric oxide-donating aspirin (NCX 4016): an overview of its pharmacological properties and clinical perspectives. 106
Mechanisms of thrombocytopenia in platelet-type von Willebrand disease 106
Choline plasmalogen biosynthesis by transmethylation in human platelets 105
Anti-platelet therapy: phosphodiesterase inhibitors. 105
Effect of First Long-Term Training on Whole Blood Count and Blood Clotting Parameters in Thoroughbreds 105
Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML 104
Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders. 104
Protein kinase C inhibitors enhance G-protein induced phospholipase A2 activation in intact human platelets 104
Nitric oxide enhances the anti-inflammatory and anti-atherogenic activity of atorvastatin in a mouse model of accelerated atherosclerosis. 104
The release of arachidonic acid (AA ) by human platelets stimulated by fluoroaluminate and low concetration of collagene potentiated by inhibitors of protein kinase C (PKC). 102
In vitro effect of anti-β2 glycoprotein I antibodies on P-selectin expression: a marker of platelet activation 102
A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders 102
Anti-platelet treatments in cancer: Basic and clinical research 102
Association of Neutrophil Activation, More Than Platelet Activation, with Thrombotic Complications in Coronavirus Disease 2019 102
Down-regulation of fluoroaluminate-induced release of arachidonic acid by protein kinase C is calcium-dependent and not related to secretory phospholipase A2 101
Assessment of occlusion of the vascular access in patients on chronic hemodialysis: comparison of physical examination with continuous-wave doppler ultrasound. 101
Arterite temporale occulta: contributo casistico e revisione della letteratura 100
Heparin in the prophylaxis and treatment of venous thromboembolism and other thrombotic diseases. 100
Platelets contribute to the accumulation of matrix metalloproteinase type 2 in synovial fluid in osteoarthritis 100
Prevalence of thrombophilic genetic mutations in patients undergoing thrombotic events while on oral anticoagulants a case-control study 100
Endothelial dysfunction in patients with spontaneous venous thromboembolism. 99
Platelet thromboxane A2 receptor number and function in normal and in hypertensive pregnancy. 98
Acetylsalicylic acid, BM 13.177 and picotamide improve the survival of endotoxin-infused rabbits 98
A dichotomy in platelet activation: Evidence of different functional platelet responses to inflammatory versus haemostatic stimuli 98
Apparent genotype-phenotype mismatch in a patient with MYH9-related disease: when the exception proves the rule. 97
Eltrombopag in preparation for surgery in patients with severe MYH9-related thrombocytopenia. 97
Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC 97
Gestational diabetes mellitus is associated with in vivo platelet activation and platelet hyperreactivity 96
Megakaryocytes differentially sort mRNAs for matrix metalloproteinases and their inhibitors into platelets: a mechanism for regulating synthetic events. 96
Emergency management in patients with haemophilia A and inhibitors on prophylaxis with emicizumab: AICE practical guidance in collaboration with SIBioC, SIMEU, SIMEUP, SIPMeL and SISET 96
ABO Blood Group and Inhibitor Risk in Severe Hemophilia A Patients: A Study from the Italian Association of Hemophilia Centers 96
Inherited disorders and gene regulation of platelet signal transduction: the picture is expanding. 95
Differences between human platelets erythrocyte membranes.A spectroscopic study with particular refernce to IR and Laser Raman spectroscopy. 95
Effect of different plasma expanders on erythrocyte filterability 95
I peptidil leucotrieni regolano la secrezione di pepsinogeno e la mobilitazione del calcio nelle cellule principali isolate 95
A novel variant Glanzmann thrombasthenia due to co-inheritance of a loss- and a gain-of-function mutation of ITGB3: evidence of a dominant effect of gain-of-function mutations. 95
MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness. 94
Peripheral arteriopathy: effects of cloricromene on claudication and quality of life, a randomized double blind,,placebo controlled trial in patients treated with aspirin 94
Selective cytochrome c displacement by phosphate and Ca2+ in brain mitochondria 94
Adenylate cyclase activation determines the effect of thromboxane synthase inhibitors on platelet aggregation in vitro. 94
Curated disease-causing genes for bleeding, thrombotic, and platelet disorders: Communication from the SSC of the ISTH. 94
[Occult temporal arteritis. Case reports and review of the literature]. 94
Established and new antiplatelet therapies 93
Effect of nitric oxide-donating agents on human monocyte cyclooxygenase-2. 93
Totale 11.758
Salva come PNG Salva come JPEG
Categoria #
all - tutte 150.897
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 150.897
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021927 0 0 0 0 0 0 0 0 0 110 299 518
2021/20223.196 75 630 79 129 104 22 37 998 43 113 416 550
2022/20235.964 462 1.152 97 451 461 684 6 253 2.128 19 161 90
2023/20242.648 138 203 121 41 29 13 1.019 52 220 99 412 301
2024/20255.200 55 556 145 195 684 241 188 409 1.195 311 791 430
2025/202610.770 819 737 604 1.493 1.632 984 2.039 470 1.229 763 0 0
Totale 34.454